The proto-oncogene function of Mdm2 in bone.
David J OlivosDaniel S PerrienAdam HookerYing-Hua ChengRobyn K FuchsJung Min HongAngela BruzzanitiKristin ChunChristine M EischenMelissa A KacenaLindsey D MayoPublished in: Journal of cellular biochemistry (2018)
Mouse double minute 2 (Mdm2) is a multifaceted oncoprotein that is highly regulated with distinct domains capable of cellular transformation. Loss of Mdm2 is embryonically lethal, making it difficult to study in a mouse model without additional genetic alterations. Global overexpression through increased Mdm2 gene copy number (Mdm2Tg ) results in the development of hematopoietic neoplasms and sarcomas in adult animals. In these mice, we found an increase in osteoblastogenesis, differentiation, and a high bone mass phenotype. Since it was difficult to discern the cell lineage that generated this phenotype, we generated osteoblast-specific Mdm2 overexpressing (Mdm2TgOb ) mice in 2 different strains, C57BL/6 and DBA. These mice did not develop malignancies; however, these animals and the MG63 human osteosarcoma cell line with high levels of Mdm2 showed an increase in bone mineralization. Importantly, overexpression of Mdm2 corrected age-related bone loss in mice, providing a role for the proto-oncogenic activity of Mdm2 in bone health of adult animals.
Keyphrases
- copy number
- bone loss
- genome wide
- healthcare
- mitochondrial dna
- public health
- endothelial cells
- cell proliferation
- soft tissue
- dna methylation
- risk assessment
- single cell
- stem cells
- bone regeneration
- type diabetes
- bone marrow
- metabolic syndrome
- gene expression
- postmenopausal women
- insulin resistance
- climate change
- adipose tissue
- mesenchymal stem cells
- human health
- cell fate